quinuclidines has been researched along with maropitant in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (16.92) | 29.6817 |
| 2010's | 39 (60.00) | 24.3611 |
| 2020's | 15 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Tilt, N | 1 |
| Benchaoui, HA; Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Siedek, EM; Tilt, N | 2 |
| van Noort, R | 1 |
| de la Puente-Redondo, V; Hickman, MA; Schneider, RP; Tingley, FD | 1 |
| Benchaoui, HA; Boucher, JF; Clemence, RG; Cox, SR; Schneider, RP | 1 |
| Bunger, A; Cox, SR; Hickman, MA; Lin, J; Mahabir, S; McCall, RB; Miskell, C | 1 |
| Boucher, JF; Clemence, RG; Conder, GA; Sedlacek, HS | 1 |
| Boucher, JF; Clemence, RG; Conder, GA; Eagleson, JS; Ramsey, DS; Sedlacek, HS | 1 |
| Boucher, JF; Clemence, RG; Conder, GA; Eagleson, JS; Kincaid, K; Ramsey, DS; Watkins, JA | 1 |
| Aleo, M; Coscarelli, E; Fleck, T; Galvan, B; Humphrey, W; McCall, RB; Narishetty, ST | 1 |
| Trepanier, L | 1 |
| Shukla, A | 1 |
| Carlson Scholz, JA; Deng, Y; Franklin, R; Smith, PC; Williams-Fritze, MJ; Wilson, SR; Zeiss, C | 1 |
| Alibhai, HI; Lee, K; Mathis, A | 1 |
| Alvillar, BM; Boscan, P; Congdon, J; Ferreira, TH; Mama, KR; Twedt, DC | 1 |
| Boscan, P; Congdon, J; Mama, K; Monnet, E; Steffey, EP; Twedt, DC | 1 |
| Hay Kraus, BL | 3 |
| Bidgood, TL; Boucher, JF; Cox, SR; Grover, GS; Lesman, SP | 1 |
| Boscan, P; Eickhoff, JC; Monnet, E; Niyom, S; Twedt, DC | 1 |
| Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
| Johnson, RA | 1 |
| Cooke, K; Isaza, N; Koh, RB; Robertson, SA; Xie, H | 1 |
| Borrego, JF; Huelsmeyer, MK; Kurzman, ID; Miller, SA; Muszynski, JL; Pinkerton, ME; Vail, DM | 1 |
| Abreu, M; Aguado, D; Benito, J; García-Fernández, J; Gómez de Segura, IA | 1 |
| Blackwood, L; Cripps, P; Elliott, J; Grant, IA; Mason, SL | 1 |
| Bolotin, D; Brock, WT; Moses, K; Patricelli, K; Quimby, JM | 1 |
| Hori, M; Islam, MS; Kaji, N; Mikawa, S; Mizuno, R; Murata, T; Ozaki, H; Yamamoto, S | 1 |
| Dodam, JR; Grobman, M; Krumme, S; Outi, H; Reinero, CR | 1 |
| Himelfarb, MA; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP | 1 |
| Boscan, P; Marquez, M; Twedt, DC; Vogel, P; Weir, H | 1 |
| Boesch, JM; Campoy, L; Gleed, RD; Kirch, PJ; Learn, MM; Martin-Flores, M; Mastrocco, A; Sakai, DM | 1 |
| Grobman, M; Reinero, C | 1 |
| Borsch, C; Clemence, R; Failing, K; Fink, T; Kunz, C; Neiger, R; Savary-Bataille, K; Schmitz, S | 1 |
| Boesch, JM; Campoy, L; Gleed, RD; Learn, MM; Martin-Flores, M; Mastrocco, A; Sakai, DM | 1 |
| Boesch, JM; Campoy, L; Kirch, P; Learn, MM; Lorenzutti, AM; Martin-Flores, M; Mastrocco, A; Stone, M | 1 |
| Himelfarb, MA; Invaldi, SH; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP | 1 |
| Fukui, S; Ishizuka, T; Itami, T; Miyoshi, K; Ooyama, N; Sano, T; Tamura, J; Umar, MA; Yamashita, K | 1 |
| Keser, GO; Yalcin, E | 1 |
| Dugdale, A; Elmer, T; Rioja, E; Swallow, A | 1 |
| Haruki, N; Hori, M; Inomata, T; Ohgoda, M; Tsukamoto, A | 1 |
| Chang, S; Dierks, E; MacGuire, J; Roble, GS; Steinbach, JR | 1 |
| Fontaine, J; Maina, E | 1 |
| Cartagena-Albertus, JC; Engel Manchado, J; Moise, A; Montoya Alonso, JA; Moya García, S | 1 |
| Chambers, P; Karna, SR; Kongara, K; Lopez-Villalobos, N; Singh, PM | 1 |
| Berryhill, EH; Edman, JM; Knych, H; Magdesian, KG | 1 |
| Furumoto, K; Itoi, T; Iwata, E; Kanda, T; Morimoto, H; Okamura, Y; Shimizu, Y; Toda, C | 1 |
| Fransson, BA; Jones, CT | 1 |
| Drazenovich, TL; Hawkins, MG; Kass, PH; Knych, HK; Ozawa, SM | 1 |
| Chambers, P; Karna, SR; Kongara, K; Singh, P | 1 |
| Berryhill, EH; Chigerwe, M; Edman, J; Knych, H; Magdesian, KG | 1 |
| Chi, TT; Hay Kraus, BL | 1 |
| Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C | 1 |
| Chambers, P; Johnson, CB; Karna, SR; Kongara, K; Lopez-Villalobos, N; Singh, P; Stewart, LA | 1 |
| Glanemann, B; McCormack, R; Olley, L; Swann, JW | 1 |
| Hoelzler, MG; Park, LS | 1 |
| Beier, SL; Corrêa, JMX; Lavor, MSL; Marques, CSDC; Niella, RV; Oliveira, JNS; Pinto, TM; Silva Junior, AC; Silva, EBD; Silva, FL | 1 |
| Bergman, PJ; McKee, TS; Moyer, AL; Vinayak, A | 1 |
| Burke, JE; Hess, RS; Silverstein, DC | 1 |
| Fukazawa, E; Harada, K; Ichimata, M; Kobayashi, T; Matsuyama, F; Nakano, Y | 1 |
| Guzman, DS; Knych, HK; Mones, AB; Petritz, OA; Sadar, MJ; Thomson, AE | 1 |
| Akcakavak, G; Canbar, R; Uslu, M; Yazar, E | 1 |
| Menard, J; Ochigbo, G; Rosa, BV; Yee, DE | 1 |
2 review(s) available for quinuclidines and maropitant
| Article | Year |
|---|---|
Acute vomiting in cats: rational treatment selection.
Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indoles; Metoclopramide; Nausea; Ondansetron; Prochlorperazine; Quinolizines; Quinuclidines; Ranitidine; Sucralfate; Vomiting; Weight Loss | 2010 |
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |
33 trial(s) available for quinuclidines and maropitant
| Article | Year |
|---|---|
Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dog Diseases; Dogs; Female; Least-Squares Analysis; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2007 |
The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Europe; Female; Male; Quinuclidines; Treatment Outcome; Vomiting | 2007 |
The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
Topics: Animals; Antiemetics; Brain; Dogs; Gerbillinae; Male; Models, Animal; Motor Activity; Neurokinin-1 Receptor Antagonists; Quinuclidines | 2007 |
Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.
Topics: Animals; Antiemetics; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Motion Sickness; Quinuclidines; Treatment Outcome; Vomiting | 2007 |
Effect of refrigeration of the antiemetic Cerenia (maropitant) on pain on injection.
Topics: Animals; Antiemetics; beta-Cyclodextrins; Dog Diseases; Dogs; Excipients; Pain; Quinuclidines; Refrigeration | 2009 |
Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Injections, Intramuscular; Male; Preanesthetic Medication; Quinuclidines; Vomiting | 2013 |
Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats.
Topics: Anesthetics, Inhalation; Animals; Cats; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Methyl Ethers; Neurokinin-1 Receptor Antagonists; Ovariectomy; Quinuclidines; Sevoflurane | 2013 |
Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
Topics: Acepromazine; Analgesics, Opioid; Anesthesia, Inhalation; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Esophagus; Female; Gastroesophageal Reflux; Hydrogen-Ion Concentration; Hydromorphone; Male; Quinuclidines; Vomiting | 2014 |
Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Electroacupuncture; Female; Male; Morphine; Quinuclidines; Vomiting | 2014 |
Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Male; Quinuclidines; Vomiting | 2014 |
Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
Topics: Animals; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Lymphoma; Male; Quinuclidines; Vincristine | 2014 |
Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Drug Administration Schedule; Female; Hydromorphone; Male; Nausea; Quinuclidines; Vomiting | 2014 |
Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
Topics: Animals; Cat Diseases; Cats; Double-Blind Method; Kidney Function Tests; Palliative Care; Quinuclidines; Renal Insufficiency, Chronic; Vomiting | 2015 |
Acute neurokinin-1 receptor antagonism fails to dampen airflow limitation or airway eosinophilia in an experimental model of feline asthma.
Topics: Animals; Asthma; Cat Diseases; Cats; Cross-Over Studies; Disease Models, Animal; Eosinophilia; Immunotherapy, Active; Prospective Studies; Quinuclidines; Receptors, Neurokinin-1 | 2016 |
Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dogs; Drug Interactions; Female; Male; Morphine; Prospective Studies; Quinuclidines; Salivation; Single-Blind Method; Vomiting | 2016 |
Evaluation of oral maropitant as an antiemetic in cats receiving morphine and dexmedetomidine.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Cats; Dexmedetomidine; Female; Hysterectomy; Morphine; Ovariectomy; Prospective Studies; Quinuclidines; Treatment Outcome; Vomiting | 2016 |
Effects of the neurokinin-1 antagonist maropitant on canine gastric emptying assessed by radioscintigraphy and breath test.
Topics: Animals; Breath Tests; Cisapride; Cross-Over Studies; Dog Diseases; Dogs; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Neurokinin-1 Receptor Antagonists; Quinuclidines; Radionuclide Imaging | 2016 |
Effects of maropitant in cats receiving dexmedetomidine and morphine.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Cat Diseases; Cats; Dexmedetomidine; Drug Interactions; Female; Injections, Intramuscular; Injections, Subcutaneous; Morphine; Nausea; Quinuclidines; Single-Blind Method; Visual Analog Scale; Vomiting | 2016 |
Maropitant administered orally 2-2.5 h prior to morphine and dexmedetomidine reduces the incidence of emesis in cats.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Antiemetics; Cat Diseases; Cats; Dexmedetomidine; Female; Injections, Intramuscular; Morphine; Ovariectomy; Postoperative Nausea and Vomiting; Quinuclidines; Treatment Outcome | 2017 |
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Male; Metoclopramide; Morphine; Nausea; Orchiectomy; Ovariectomy; Quinuclidines; Vomiting | 2017 |
Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Topics: Animals; Antiemetics; Dog Diseases; Dogs; Female; Male; Metoclopramide; Ondansetron; Parvoviridae Infections; Parvovirus, Canine; Quinuclidines; Treatment Outcome; Vomiting | 2017 |
The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Isoflurane; Ovariectomy; Postoperative Nausea and Vomiting; Quinuclidines | 2017 |
Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.
Topics: Animals; Antidiarrheals; Antiemetics; Antineoplastic Agents, Phytogenic; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Loperamide; Male; Neoplasms; Paclitaxel; Quinuclidines; Random Allocation; Vomiting | 2019 |
Pharmacokinetics of single doses of maropitant citrate in adult horses.
Topics: Animals; Antiemetics; Area Under Curve; Cross-Over Studies; Female; Half-Life; Horses; Male; Quinuclidines | 2019 |
Antiemetic effect of oral maropitant treatment before the administration of brimonidine ophthalmic solution in healthy cats.
Topics: Administration, Oral; Animals; Antiemetics; Brimonidine Tartrate; Cats; Cross-Over Studies; Ophthalmic Solutions; Quinuclidines; Reference Values | 2020 |
Evaluation of the effectiveness of preoperative administration of maropitant citrate and metoclopramide hydrochloride in preventing postoperative clinical gastroesophageal reflux in dogs.
Topics: Animals; Dog Diseases; Dogs; Dopamine D2 Receptor Antagonists; Female; Gastroesophageal Reflux; Male; Metoclopramide; Postoperative Care; Quinuclidines | 2019 |
Pharmacokinetics of maropitant citrate in New Zealand White rabbits (
Topics: Animals; Biological Availability; Female; Half-Life; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Rabbits | 2019 |
Pharmacokinetics of morphine in combination with dexmedetomidine and maropitant following intramuscular injection in dogs anaesthetized with halothane.
Topics: Analgesics, Opioid; Anesthetics, Inhalation; Animals; Antiemetics; Area Under Curve; Cross-Over Studies; Dexmedetomidine; Dogs; Drug Therapy, Combination; Half-Life; Halothane; Hypnotics and Sedatives; Injections, Intramuscular; Morphine; Quinuclidines | 2020 |
Pharmacokinetics of maropitant citrate after oral administration of multiple doses in adult horses.
Topics: Administration, Oral; Animals; Antiemetics; Area Under Curve; Drug Administration Schedule; Female; Half-Life; Horses; Male; Quinuclidines | 2020 |
Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Topics: Animals; Antiemetics; Antifibrinolytic Agents; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Ondansetron; Prospective Studies; Quinuclidines; Tranexamic Acid; Vomiting | 2020 |
Effect of combinations of morphine, dexmedetomidine and maropitant on the electroencephalogram in response to acute electrical stimulation in anaesthetized dogs.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia, General; Animals; Antiemetics; Cross-Over Studies; Dexmedetomidine; Dogs; Electric Stimulation; Electroencephalography; Morphine; Quinuclidines | 2020 |
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromorphone; Nausea; Ondansetron; Quinuclidines; Vomiting | 2021 |
Dilution of maropitant (Cerenia) in lactated Ringer solution prolongs subcutaneous drug absorption and reduces maximum plasma concentration.
Topics: Animals; Cross-Over Studies; Dogs; Female; Pharmaceutical Preparations; Quinuclidines; Ringer's Lactate | 2023 |
30 other study(ies) available for quinuclidines and maropitant
| Article | Year |
|---|---|
[New antiemetics: maropitant citrate].
Topics: Animals; Antiemetics; Quinuclidines; Vomiting | 2007 |
The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
Topics: Administration, Oral; Animals; Antiemetics; Area Under Curve; Dogs; Female; Injections, Subcutaneous; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines | 2007 |
Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
Topics: Animals; Cats; Female; Male; Metabolic Clearance Rate; Motion Sickness; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.
Topics: Animals; Cross-Over Studies; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Male; Motion Sickness; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
Topics: Animals; Apomorphine; Cross-Over Studies; Dogs; Emetics; Humans; Ipecac; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
Topics: Administration, Oral; Animals; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Injections, Subcutaneous; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting | 2008 |
Acute pancreatitis attributed to dietary indiscretion in a female mixed breed canine.
Topics: Acute Disease; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Dehydration; Dog Diseases; Dogs; Female; Medical History Taking; Meloxicam; Pancreatitis; Quinuclidines; Radiography; Tachycardia; Thiazines; Thiazoles; Treatment Outcome; Vomiting | 2010 |
Maropitant citrate for treatment of ulcerative dermatitis in mice with a C57BL/6 background.
Topics: Animals; Antipruritics; Dermatitis; Female; Male; Mice; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Pruritus; Quinuclidines; Rodent Diseases; Skin Ulcer; Substance P | 2011 |
The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog.
Topics: Anesthesia, Epidural; Animals; Antiemetics; Dog Diseases; Dogs; Male; Morphine; Narcotics; Quinuclidines; Vomiting | 2011 |
Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antiemetics; Dogs; Female; Injections, Epidural; Injections, Intravenous; Methyl Ethers; Neurokinin-1 Receptor Antagonists; Pulmonary Alveoli; Quinuclidines; Sevoflurane | 2012 |
Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antiemetics; Dogs; Female; Infusions, Intravenous; Laparoscopy; Ligaments; Methyl Ethers; Neurokinin-1 Receptor Antagonists; Ovary; Pulmonary Alveoli; Quinuclidines; Sevoflurane; Visceral Pain | 2011 |
The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 days consecutive days.
Topics: Administration, Oral; Animals; Antiemetics; Dogs; Drug Administration Schedule; Female; Male; Quinuclidines | 2013 |
Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.
Topics: Animals; Cell Line, Tumor; Dog Diseases; Dogs; Gene Expression Regulation, Neoplastic; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Neurokinin-1 Receptor Antagonists; Quinuclidines; Receptors, Neurokinin-1; RNA, Messenger | 2016 |
Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study.
Topics: Amitriptyline; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Hyperalgesia; Male; Methyl Ethers; Minocycline; Nociception; Pain Threshold; Piperidines; Pulmonary Alveoli; Quinuclidines; Random Allocation; Rats, Wistar; Remifentanil; Sevoflurane | 2015 |
Anti-emetic drug maropitant induces intestinal motility disorder but not anti-inflammatory action in mice.
Topics: Animals; Antiemetics; Gastrointestinal Motility; Ileus; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Muscle, Smooth; Neutrophils; Quinuclidines; Tissue Culture Techniques | 2015 |
Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy.
Topics: Analgesics; Animals; Dogs; Female; Morphine; Ovariectomy; Pain Management; Pain Measurement; Pain, Postoperative; Premedication; Quinuclidines; Receptors, Neurokinin-1 | 2015 |
Investigation of Neurokinin-1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs.
Topics: Animals; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Cough; Dog Diseases; Dogs; Eosinophils; Female; Male; Neurokinin-1 Receptor Antagonists; Neutrophils; Quinuclidines | 2016 |
Interaction between maropitant and carprofen on sparing of the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs.
Topics: Anesthesia; Anesthetics; Anesthetics, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Male; Methyl Ethers; Neurokinin-1 Receptor Antagonists; Premedication; Pulmonary Alveoli; Quinuclidines; Sevoflurane | 2017 |
The anti-inflammatory action of maropitant in a mouse model of acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Neurokinin-1 Receptor Antagonists; Pancreatitis; Peroxidase; Quinuclidines; Receptors, Neurokinin-1; Substance P | 2018 |
Assessment of pre-operative maropitant citrate use in macaque (Macaca fasicularis & Macaca mulatta) neurosurgical procedures.
Topics: Animals; Antiemetics; Macaca fascicularis; Macaca mulatta; Male; Monkey Diseases; Postoperative Nausea and Vomiting; Preoperative Period; Prospective Studies; Quinuclidines; Retrospective Studies | 2018 |
Use of maropitant for the control of pruritus in non-flea, non-food-induced feline hypersensitivity dermatitis: an open-label, uncontrolled pilot study.
Topics: Animals; Cat Diseases; Cats; Dermatitis, Atopic; Female; Immunosuppressive Agents; Male; Pilot Projects; Pruritus; Quinuclidines | 2019 |
Evaluation of analgesic interaction between morphine, dexmedetomidine and maropitant using hot-plate and tail-flick tests in rats.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Dexmedetomidine; Drug Synergism; Drug Therapy, Combination; Male; Morphine; Pain; Pain Measurement; Quinuclidines; Random Allocation; Rats; Rats, Sprague-Dawley | 2019 |
The effect of intravenous maropitant on blood pressure in healthy awake and anesthetized dogs.
Topics: Acepromazine; Anesthesia, Inhalation; Animals; Antiemetics; Blood Pressure; Dog Diseases; Dogs; Female; Heart Rate; Humans; Hypotension; Injections, Intravenous; Linear Models; Models, Animal; Premedication; Quinuclidines; Wakefulness | 2020 |
Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care.
Topics: Animals; Dog Diseases; Dogs; Drug Prescriptions; Gastrointestinal Diseases; Hospitalization; Omeprazole; Practice Patterns, Physicians'; Prospective Studies; Quinuclidines | 2020 |
Retrospective evaluation of maropitant and perioperative factors affecting postoperative appetite in cats.
Topics: Animals; Appetite; Buprenorphine; Cats; Quinuclidines; Retrospective Studies | 2021 |
Antinociceptive and analgesic effect of continuous intravenous infusion of maropitant, lidocaine and ketamine alone or in combination in cats undergoing ovariohysterectomy.
Topics: Analgesics; Animals; Cat Diseases; Cats; Female; Infusions, Intravenous; Ketamine; Lidocaine; Ovariectomy; Pain, Postoperative; Quinuclidines | 2021 |
Low incidence of postoperative nausea, vomiting, regurgitation, and aspiration pneumonia in geriatric dogs receiving maropitant, famotidine, and fentanyl as part of an anesthesia protocol.
Topics: Anesthesia; Animals; Antiemetics; Dog Diseases; Dogs; Famotidine; Fentanyl; Incidence; Pneumonia, Aspiration; Postoperative Nausea and Vomiting; Quinuclidines | 2021 |
Evaluation of adverse events in small-breed dogs treated with maropitant and a single dose of doxorubicin.
Topics: Animals; Diarrhea; Dog Diseases; Dogs; Doxorubicin; Neoplasms; Neutropenia; Prospective Studies; Quinuclidines; Vomiting | 2022 |
Pharmacokinetics of maropitant citrate in Rhode Island Red chickens (Gallus gallus domesticus) following subcutaneous administration.
Topics: Animals; Cats; Chickens; Cross-Over Studies; Dogs; Female; Quinuclidines; Rhode Island | 2022 |
Determination of the embryotoxic effect of maropitant using an in ovo model.
Topics: Animals; Chickens; Injections; Quinuclidines; Saline Solution | 2022 |